Home » Newsletters » BioWorld

BioWorld

March 19, 1992

View Archived Issues

AGRACETUS LICENSES COTTON TECHNOLOGY

LTIZ RAISES $32M FOR CANCER PROGRAMS

QUADRA LOGIC ADOPTS POISON PILL

INSITE GETS SBIR TO SCALE UP DRUG

GENZYME HA MEMBRANE ENTERS CLINIC

BLOOD SUBSITUTE SHOWS EARLY PROMISE

LICENSING STRATEGY ATTRACTS $22.4 M IN IPO

ANALYST RECOMMENDATION BOOSTS SYGN

DNASE HELPS CLEAR LUNGS OF CF PATIENTS